Femaford 2.5mg contains Letrozole, an aromatase inhibitor that helps reduce estrogen levels in the body. By inhibiting aromatase, Letrozole suppresses estrogen production, which can be beneficial in various conditions affecting women’s health. In fertility treatments, it promotes ovulation by stimulating the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH), thus increasing the chances of conception. For women with polycystic ovary syndrome (PCOS), Letrozole helps regulate menstrual cycles and improve ovulation, enhancing fertility. Additionally, Femaford 2.5mg is prescribed as an adjuvant therapy for hormone receptor-positive breast cancer, where it aids in reducing the risk of cancer recurrence.